MRCP Management of Relapse List

 TL;DR

List: MRCP "Management of Relapse" List is a useful revision framework for MRCP Part 1 because relapse management principles appear across rheumatology, gastroenterology, neurology, nephrology and respiratory medicine. Rather than memorising disease-specific protocols, candidates should understand the common principles that determine investigation, treatment escalation and prevention of future relapse. This guide summarises the highest-yield concepts, common examination traps, and a practical revision checklist.

Why this matters

Many inflammatory and autoimmune disorders follow a relapsing-remitting course. Examples include:

• Crohn's disease

• Ulcerative colitis

• Multiple sclerosis

• ANCA-associated vasculitis

• Systemic lupus erythematosus

• Minimal change nephrotic syndrome

• Immune thrombocytopenia

• Autoimmune hepatitis

The examination frequently tests whether the candidate can distinguish:

• relapse versus treatment failure

• relapse versus infection

• relapse versus medication toxicity

• relapse versus irreversible disease progression

Recognising these distinctions prevents inappropriate treatment and improves patient outcomes.

Core principles of relapse management

1. Confirm that a true relapse has occurred

Symptoms alone are insufficient.

Always consider:

• infection

• poor treatment adherence

• medication adverse effects

• new comorbidity

• alternative diagnosis

Investigations should support active disease before escalating immunosuppression whenever possible.

2. Assess disease severity

Severity determines urgency.

Typical features suggesting severe relapse include:

• haemodynamic instability

• rapidly progressive organ dysfunction

• neurological deficit

• significant bleeding

• respiratory compromise

• renal impairment

Patients with severe disease often require hospital admission and specialist involvement.

3. Identify precipitating factors

Common triggers include:

• stopping maintenance therapy

• infection

• pregnancy

• surgery

• physiological stress

• smoking (especially Crohn's disease)

• medication interactions

Treating the trigger reduces recurrence.

4. Repeat appropriate investigations

The exact investigations depend on the disease but commonly include:

Investigation	Purpose
FBC	Anaemia, infection, cytopenias
CRP/ESR	Inflammatory activity
U&E	Renal function
LFTs	Drug toxicity and systemic disease
Urinalysis	Renal relapse
Imaging	Organ involvement
Disease-specific biomarkers	Confirm activity
Microbiology	Exclude infection before immunosuppression

5. Treat the acute relapse promptly

High-yield principles include:

• corticosteroids remain first-line for many inflammatory relapses

• severe relapse may require intravenous therapy

• biological agents are considered when conventional therapy fails

• supportive management is equally important

• monitor treatment response closely

Remember that not every relapse requires escalation to biologics.

6. Escalate maintenance therapy appropriately

Following recovery, ask:

Why did relapse occur?

Possible reasons include:

• inadequate maintenance treatment

• poor compliance

• resistant disease

• inappropriate drug choice

• premature withdrawal of therapy

Long-term management should be adjusted to reduce future relapse risk.

7. Monitor for complications

Relapse management includes monitoring both disease and treatment complications.

Examples:

Disease complications

• thrombosis

• renal failure

• bowel perforation

• neurological disability

Treatment complications

• opportunistic infection

• osteoporosis

• diabetes

• hypertension

• cytopenias

• hepatotoxicity

8. Prevent future relapse

Relapse prevention often scores easy examination marks.

Strategies include:

• medication adherence

• smoking cessation

• vaccination where appropriate

• regular follow-up

• monitoring inflammatory markers

• patient education

• early recognition of warning symptoms

9. Know when surgery is required

Medical therapy is not always sufficient.

Examples include:

• toxic megacolon

• bowel perforation

• severe ulcerative colitis refractory to treatment

• abscess formation

• obstructive complications

Candidates should recognise when escalation beyond medical management is indicated.

10. Involve the multidisciplinary team

Management often requires:

• physicians

• surgeons

• specialist nurses

• pharmacists

• physiotherapists

• dietitians

• psychologists

The MRCP examination increasingly reflects multidisciplinary care.

Five most tested relapse scenarios

1. Inflammatory bowel disease

Know:

• differentiate relapse from infective diarrhoea

• perform stool cultures before escalating steroids

• recognise severe acute ulcerative colitis

• indications for biologics

• indications for colectomy

2. Multiple sclerosis

Focus on:

• relapse versus pseudo-relapse

• infection causing worsening symptoms

• corticosteroids for acute relapse

• disease-modifying therapy

• MRI indications

3. Systemic lupus erythematosus

Key points:

• distinguish flare from infection

• complement levels

• anti-dsDNA titres

• corticosteroid escalation

• organ-specific management

4. ANCA-associated vasculitis

Remember:

• renal function

• pulmonary haemorrhage

• immunosuppressive induction

• maintenance therapy

• relapse monitoring

5. Nephrotic syndrome

High-yield concepts:

• proteinuria monitoring

• oedema management

• steroid-responsive relapse

• thromboembolism risk

• infection prevention

Practical revision list

When answering any relapse question, mentally work through the following checklist:

1. Confirm active disease.

2. Exclude infection.

3. Assess severity.

4. Identify precipitating factors.

5. Perform appropriate investigations.

6. Initiate acute treatment.

7. Monitor response.

8. Escalate maintenance if necessary.

9. Prevent future relapse.

10. Arrange follow-up.

This simple sequence applies across multiple specialties and can rapidly narrow the correct answer in single-best-answer questions.

Practical examples / mini-cases

Mini-case

A 32-year-old woman with Crohn's disease develops worsening abdominal pain and diarrhoea after stopping azathioprine three months ago. CRP is elevated. Stool culture is pending.

Question

What is the most appropriate immediate next step?

A. Start infliximab immediately

B. Restart maintenance therapy only

C. Exclude infection before escalating immunosuppression

D. Arrange bowel surgery immediately

E. Discontinue all medication

Correct answer: C

Explanation

The first priority is to confirm that symptoms represent inflammatory relapse rather than infectious gastroenteritis. Stool cultures and appropriate microbiological investigations should be obtained before escalating corticosteroids or biological therapy. Once infection has been excluded, treatment can be tailored according to disease severity.

Common pitfalls (5 bullets)

• Escalating immunosuppression before excluding infection.

• Treating symptoms without assessing disease severity.

• Forgetting medication non-adherence as a common cause of relapse.

• Confusing irreversible disease progression with active inflammatory relapse.

• Neglecting long-term relapse prevention after successful treatment.

Practical study-tip checklist

Before the examination, ensure you can answer the following for every relapsing condition:

• □ What defines relapse?

• □ Which investigations confirm active disease?

• □ Which conditions mimic relapse?

• □ What is first-line treatment?

• □ When should treatment be escalated?

• □ What are the major complications?

• □ Which maintenance therapies reduce recurrence?

• □ When is surgery indicated?

• □ What follow-up is recommended?

• □ What preventive advice should patients receive?

FAQs

What does MRCP Part 1 expect candidates to know about relapse management?

MRCP Part 1 focuses on recognising relapse, confirming active disease, excluding mimics such as infection, and understanding appropriate treatment escalation rather than memorising detailed specialist protocols.

Why is infection important before treating relapse?

Many inflammatory diseases are treated with immunosuppressive drugs. Escalating treatment in an unrecognised infection can worsen outcomes, making exclusion of infection a key examination principle.

Which specialties commonly test relapse management?

Relapse questions commonly appear in gastroenterology, rheumatology, nephrology, neurology, respiratory medicine and haematology.

Are biological therapies heavily examined?

Candidates should understand when biologics are indicated, but examinations more commonly assess the principles behind escalation rather than detailed prescribing regimens.

How should I revise relapse management efficiently?

Use disease-based revision alongside pattern recognition. Compare different relapsing conditions and identify shared principles such as confirmation of relapse, exclusion of infection, severity assessment and maintenance optimisation.

Ready to start?

Relapse management is a recurring theme throughout MRCP Part 1. Building a framework-based approach will help you answer questions across multiple specialties with greater confidence.

Continue your preparation with:

• MRCP Part 1 overview: /mrcp-part-1/

• Free MRCP QBank: /qbank/

• MRCP Lectures: /lectures/

• Mock examinations: /mock-tests/

Sources

1. MRCP(UK). https://www.mrcpuk.org/

2. National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk/

3. European Alliance of Associations for Rheumatology (EULAR). https://www.eular.org/

4. British Society of Gastroenterology. https://www.bsg.org.uk/

5. KDIGO Clinical Practice Guidelines. https://kdigo.org/

6. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). https://ectrims.eu/